Correlation Between Scpharmaceuticals and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Scpharmaceuticals and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Pasithea Therapeutics.
Diversification Opportunities for Scpharmaceuticals and Pasithea Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Scpharmaceuticals and Pasithea is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and Pasithea Therapeutics
Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Pasithea Therapeutics. In addition to that, Scpharmaceuticals is 1.29 times more volatile than Pasithea Therapeutics Corp. It trades about -0.23 of its total potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.24 per unit of volatility. If you would invest 369.00 in Pasithea Therapeutics Corp on August 28, 2024 and sell it today you would lose (64.00) from holding Pasithea Therapeutics Corp or give up 17.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. Pasithea Therapeutics Corp
Performance |
| Timeline |
| Scpharmaceuticals |
| Pasithea Therapeutics |
Scpharmaceuticals and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and Pasithea Therapeutics
The main advantage of trading using opposite Scpharmaceuticals and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.| Scpharmaceuticals vs. Capricor Therapeutics | Scpharmaceuticals vs. Soleno Therapeutics | Scpharmaceuticals vs. Bio Path Holdings | Scpharmaceuticals vs. Moleculin Biotech |
| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |